US4039676A
Expired / Lapsed
US
⏱️ 0.0 years remaining
2-piperidinoalkyl-1,4-benzodioxans
Assignee: Novartis Corp
•
Filing: 1975-06-23
•
Granted: 1977-08-02
•
Expires: 1995-06-23
Abstract
Abstract 2-Piperidinoalkyl-1,4 benzodioxans, e.g. those of the formula ##STR1## AND ACID ADDITION SALTS THEREOF ARE NEUROLEPTIC AGENTS.
Inventors
- 👤 Charles Ferdinand Huebner
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 13:31
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/77; C07D307/78; C07D307/79; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K31/445; A61P; A61P25/00; A61P25/04; C07D211/00; C07D211/04; C07D211/06; C07D211/36; C07D211/40; C07D211/44; C07D211/52; C07D307/80; C07D319/00; C07D319/10; C07D319/14; C07D319/16; C07D319/20; C07D327/00; C07D327/02; C07D327/06; C07D411/00; C07D411/02; C07D411/06
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
61 words
A compound corresponding to the formula ##STR8## wherein R is hydrogen, methyl, ethyl, methoxy, ethoxy, methylmercapto, ethylmercapto, fluoro, chloro or trifluoromethyl, x is the integer 1 or 2, y is the integer 2 or 3, R" is hydroxy or alkanoyloxy with 2 to 12 carbon atoms, and R' is 2-, 3-, or 4-pyridyl; or a therapeutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim
61 words
A compound corresponding to the formula ##STR8## wherein R is hydrogen, methyl, ethyl, methoxy, ethoxy, methylmercapto, ethylmercapto, fluoro, chloro or trifluoromethyl, x is the integer 1 or 2, y is the integer 2 or 3, R" is hydroxy or alkanoyloxy with 2 to 12 carbon atoms, and R' is 2-, 3-, or 4-pyridyl; or a therapeutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim
19 words
A compound as claimed in claim 1, and being the 2-[2-(4-hydroxy-4-(pyridyl-3)-piperidino)-ethyl]-1,4-benzodioxan, or a therapeutically acceptable acid addition salt thereof.
Claim 4
Dependent Claim
20 words
A compound as claimed in claim 1 and being and the 2-[2-(4-hydroxy-4-(pyridyl-2)-piperidino)-ethyl]-1,4-benzodioxan, or a therapeutically acceptable acid addition salt thereof.
Claim 5
Dependent Claim
25 words
A neuroleptic or analgetic pharmaceutical composition comprising a neuroleptically or analgetically effective amount of a compound claimed in claim 1, together with a pharmaceutical excipient.
Claim 6
Dependent Claim
27 words
A method of treating aggression, agitation, anxiety or pain in mammals, which consists in administering to said mammal enterally or parenterally a composition claimed in claim 4.
References Cited (Backward Citations)
US2056046A
Cited
US2956058A
Cited
US3149108A
Cited
US3247221A
Cited
NL296841A
Cited
JPS4311456Y1
Cited
JPS422708Y1
Cited
US3426043A
Cited
US3558637A
Cited
US3513239A
Cited
US3575990A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-08-01 | 1981-01-31 | 1981-08-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-08-01 | 1985-01-31 | 1985-08-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-08-01 | 1989-01-31 | 1989-08-02 | $7700.00 | Window Closed / Lapsed |